Fullerenol C 60(OH) 24 as a potential drug;Fulerenol C 60(OH) 24 kot potencialna učinkovina

Farmacevtski Vestnik

Volumn 59, Issue 5, 2008, Pages 257-262

  Injac, Rade ^a   Kočevar, Nina ^a   Štrukelj, Borut ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Antioxidants; Fullerene; Fullerenols

Indexed keywords

ADRENALIN; ANTIOXIDANT; DOXORUBICIN; FULLERENE DERIVATIVE; FULLERENOL; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; CARDIOVASCULAR REFLEX; DRUG STRUCTURE; NONHUMAN; REVIEW;

EID: 57749203420     PISSN: 00148229     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Kroto H, Health J, O'Brien S et al. C60: Buckminsterfullerene. Nature 1985; 318: 162-163.
2. Hirsch A. The Chemistry of the Fullerenes. New York: Wiley; 1993.
3. Dresselhaus MS, Dresselhaus G, Eklund PC. Science of Fullerenes and Carbon Nanotubes. San Diego: Academic Press; 1996: 292-325.
4. Chaing LY, Lu FJ, Lin JT. Free radical scavenging activity of water soluble fullerenols. J Chem Soc Chem Commun 1995; 24 (12): 1283-1284.
5. Dugan LL, Gabrielsen JK, Yu SP et al. Buckminsterfullerenol Free Radical Scavengers reduse Exitotoxic and Apoptotic Death of Cultured Cortical Neurons. Neurobiol Dis 1996; 3 (2): 129-135. (Pubitemid 26275342)
6. Tagmatarchis N, Shinohara H. Fullerenes in Medicanal Chemistry and their Biological Applications. Mini-Rev Med Chem 2001; 1 (4): 339-348.
7. Kroto HW, Alaff W, Balm SP. C60: Buckminsterfullerene. Chem Rev 1991; 91 (6): 1213-1235.
8. 60, Zadužbina Andrejević Beograd, 2002.
9. Sayes CM, Fortner DJ, Guo W et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 2004; 4 (10): 1881-1887.
10. Foote CS. . Top Curr Chem 1997; 169: 347-363.
11. Pickering KD, Wiesner MR. Fullerol-Sensitized Production of ROS in Aqueous Solution. Environ Sci Technol 2005; 39 (5): 1359-1365.
12. 60 in the aqueous phase during UV irradiation. Environ Sci Technol 2007; 41 (7): 2529-2535.
13. Halliwell B, Gutteridge JMC. The chemistry of free radicals and related "reactive species". In: Free radicals in Biology and Medicine, 3. izdaja, Oxford University Press: Oxford 1999, 36-104.
14. Irie K, Nakamura Y, Ohigashi H et al. Photocytotoxicity of water-soluble fullerene derivatives. Biosci Biotec Bioch 1996; 60 (8): 1359-1361. (Pubitemid 26368109)
15. Culver KW, Blaese RM. Gene therapy for adenosine deaminase deficiency and malignant solid tumors. In: Wolff JA. Gene Therapeutics, Birkhäuser: Boston 1994, 263-280.
16. 24. Nitric Oxide-Biol Ch 2004; 11 (2): 201-207.
17. 24. Oxi Comm 2005; 27 (1): 213-218.
18. Fumelli C, Marconi A, Salvioli S et. al. Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis. J Invest Dermatol 2000; 115 (5): 835-841. (Pubitemid 30842392)
19. Lin AM, Chyi BY, Wang SD et al. Carboxyfullerene prevents iron-induced oxidative stress in rat brain. J Neurochem 1999; 72 (4): 1634-1640. (Pubitemid 29140838)
20. Monti D, Moretti L, Salvioli S et al. C60 Carboxyfullerene Exerts a Protective Activity against Oxydative Stress-Induced Apoptosis in Human Peripheral Blood Mononuclear Cells. Biochem Biophys Research Comm 2000; 277 (3): 711-717. (Pubitemid 30819744)
21. 60, in nitric oxide-induced relaxation of rabbit aorta. Eur J Pharm 1997; 327 (2-3): 175-181.
22. 60. FEBS Lett 1996; 389 (2): 111-114.
23. Friedman SH, DeCamp DL, Sijbesma RP et al. Inhibition of HIVp by fullerene derivatives: Model building studies and experimental verification. J Am Chem Soc 1993; 115 (15): 6506-6509. (Pubitemid 23276368)
24. Djordjevic A, Bogdanovic G, Dobric S. Fullerenes in Biomedicine. J BUON 2006; 11 (4): 391-404. (Pubitemid 46729851)
25. Mirkov S. Magistrska teza. Medicinska fakulteta. Novi Sad 2001.
26. Lu LH, Lee YT, Chen CW et al. The possible mechanisms of the antiproliferative effect of fullerenol, polyhydroxylated C60, on vascular smooth muscle cells. Brit J Pharmacol 1998; 123 (6): 1097-1102. (Pubitemid 28120506)
27. Ueng TH, Kang JJ, Wang HW et al. Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60. Toxicol Lett 1997; 19 (1): 29-37. (Pubitemid 27427506)
28. th International Congress of FIP, Barcelona, Spain 1999. Abstract book P-081, 55.
29. Murugan MA, Gangadharan B, Mathur PP. Antioxidative effect of fullerenol on goat epididymal spermatozoa. Asian J Androl 2002; 4 (2): 149-152. (Pubitemid 34716441)
30. 24 modulates growth and proliferation of K562 human erythroleukemia cell line. Advances in Simulation, Systems Theory and Systems Engineering, Skiatos, Greece, 2002. Abstract and manuscript book pp. 117-122.
31. Trajković S, Dobrić S, Djordjević A et al. Radioprotective efficiency of fullerenol in irradiation mice. Mater Sci Forum 2005; 494: 549-553. (Pubitemid 47569752)
32. 24 and amifostine in irradiated rats. Colloids Surf B Biointerfaces 2007; 58 (1): 39-43.
33. De Vita TV, Hellman JRS, Rosenberg AS. Cancer principles and practice of oncology, Philadelphia: Lippincott-Raven 1997: 375-512.
34. Abraham R, Basser RL, Green MD. A risk-benefit assessment of antracycline antibiotics in antineoplastics therapy. Drug Saf 1996; 15 (6): 406-429. (Pubitemid 27007320)
35. Hoeckman K, Van der Vijgh WJF, Vermorker JB. Clinical and predclinical modulation of chemotherapy-induced toxicity in patients with cancer. Drugs 1999; 50: 133-156.
36. 24 on doxorubicin induced cardiotoxicity in rats. Mater Sci Forum 2006; 518: 525-529.
37. 24 on a Single Dose Doxorubicin-induced Cardiotoxicity in Rats With Malignant Neoplasm. Technol Cancer Res Treat 2008; 7 (1): 15-26.